0001367644-24-000085.txt : 20240528
0001367644-24-000085.hdr.sgml : 20240528
20240528214034
ACCESSION NUMBER: 0001367644-24-000085
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240523
FILED AS OF DATE: 20240528
DATE AS OF CHANGE: 20240528
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dayal Sujata Tyagi
CENTRAL INDEX KEY: 0001536908
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 24993837
MAIL ADDRESS:
STREET 1: C/O BIOMET, INC.
STREET 2: P.O. BOX 587
CITY: WARSAW
STATE: IN
ZIP: 46581-0587
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: 240-631-3200
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
4
1
wk-form4_1716946827.xml
FORM 4
X0508
4
2024-05-23
0
0001367644
Emergent BioSolutions Inc.
EBS
0001536908
Dayal Sujata Tyagi
300 PROFESSIONAL DRIVE
GAITHERSBURG
MD
20879
1
0
0
0
0
Common Stock
2024-05-23
4
A
0
17430
0
A
63129
D
Stock Option (Right to Buy)
5.02
2024-05-23
4
A
0
25748
0
A
2031-05-22
Common Stock
25748
25748
D
Represents an annual grant of restricted stock units ("RSUs") granted under the Company's Stock Incentive plan, as amended and restated, for Board and Committee service. Each RSU represents a right to receive one share of Emergent BioSolutions Inc. (the "Company") common stock upon vesting. The shares underlying the RSUs will vest on the day prior to the one-year anniversary of the grant date ("Annual Grant Vesting Date"), subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date.
Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated, for Board and Committee service. The shares underlying the options will vest on the Annual Grant Vesting Date, subject to the reporting person remaining a member of the Company's board of directors through the Annual Grant Vesting Date. Each stock option represents a right to purchase one share of the Company's common stock upon vesting at the exercise price.
The number of options granted was determined by dividing half of the total non-employee director compensation value by the Black-Scholes value of a single option calculated as of the date of the grant.
/s/ Richard S. Lindahl, Attorney-in-fact
2024-05-28